CONSUMER STAPLES & DISCRETIONARY /
Wellness & Personal Care
Consumer products and services focused on health, wellness, and personal care beyond pharmaceuticals and healthcare services.
4 events touching this theme
- Single source3 days agoGLP-1 Drug Development
Novo's experimental obesity injection produces quarter bodyweight reduction in women
Novo disclosed that CagriSema, an experimental injection, achieved greater weight reduction than its existing Wegovy treatment in late-stage testing.
CNBC
- Single source20 days agoGLP-1 Drug Development
Eli Lilly and Novo Nordisk pursue amylin-based treatments for obesity
Eli Lilly and Novo Nordisk are developing amylin-based obesity drugs to follow their GLP-1 successes.
CNBC
- Single source22 days agoGLP-1 Drug Development
Eli Lilly's dual-drug obesity treatment demonstrates stronger weight reduction in Phase 2
Eli Lilly's combination obesity treatment shows improved weight loss results in mid-stage trial.
CNBC
- Single source23 days agoGLP-1 Drug Market
Novo Nordisk's oral obesity drug proves effective for patients transitioning from injections
Novo Nordisk's Wegovy oral formulation maintains weight-loss efficacy in real-world patients switching from injectable GLP-1 drugs.
CNBC